-
1
-
-
84870794442
-
-
GAPP Knowledge Base accessed February 29, 2012
-
GAPP Knowledge Base. http://www.hu-genavigator.net/GAPPKB/(accessed February 29, 2012).
-
-
-
-
2
-
-
85041650131
-
-
The National Human Genome Research Institute: Appendix 5 accessed February 29, 2012
-
The National Human Genome Research Institute: Appendix 5. The history of newborn phenylketonuria screening in the U.S. http://biotech.law.lsu.edu/ research/fed/tfgt/ap-pendix5.htm (accessed February 29, 2012).
-
The History of Newborn Phenylketonuria Screening in the U.S
-
-
-
3
-
-
84882736524
-
-
Department of Health and Human Services accessed February 29, 2012
-
Department of Health and Human Services: Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. 2011. http://www.hrsa.gov/ advisorycom-mittees/mchbadvisory/heritabledisorders/recommendedpanel/(accessed February 29, 2012).
-
(2011)
Secretary's Advisory Committee on Heritable Disorders in Newborns and Children
-
-
-
5
-
-
79952544235
-
Current priorities for public health practice in addressing the role of human genomics in improving population health
-
Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St Pierre J: Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med 2011; 40:486-493.
-
(2011)
Am J Prev Med
, vol.40
, pp. 486-493
-
-
Khoury, M.J.1
Bowen, M.S.2
Burke, W.3
Coates, R.J.4
Dowling, N.F.5
Evans, J.P.6
Reyes, M.7
St Pierre, J.8
-
6
-
-
24644456397
-
U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement
-
U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005; 143: 355-361.
-
(2005)
Ann Intern Med
, vol.143
, pp. 355-361
-
-
-
7
-
-
84870774814
-
-
National Institute for Help and Clinical Excellence accessed February 29, 2012
-
National Institute for Help and Clinical Excellence: CG71 familial hypercholesterolae-mia: NICE guideline. 2010. http://guidance. nice.org.uk/CG71/NICEGuidance/pdf/English (accessed February 29, 2012).
-
(2010)
CG71 Familial Hypercholesterolae-mia: NICE Guideline
-
-
-
8
-
-
59849108362
-
Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
-
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
-
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group: Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009; 11: 35-41.
-
(2009)
Genet Med
, vol.11
, pp. 35-41
-
-
-
9
-
-
84870830511
-
-
accessed February 29, 2012
-
Healthy People.gov: 2020 Topics & Objectives, Genomics. 2012. http://www.healthy-people.gov/2020/topicsobjectives2020/ob-jectiveslist.aspx? topicId = 15 (accessed February 29, 2012).
-
(2012)
Healthy People.gov: 2020 Topics & Objectives Genomics
-
-
-
10
-
-
85027925871
-
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: Summary of a public health/clinical collaborative meeting
-
Bellcross C, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, Joseph DA, Kaye C, Lubin I, Meyer LJ, Reyes M, Scheuner MT, Schully SD, Senter L, Stewart SL, St Pierre J, Westman J, Wise P, Ya ng VW, Khoury MJ: Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Genet Med 2012; 14:152-162.
-
(2012)
Genet Med
, vol.14
, pp. 152-162
-
-
Bellcross, C.1
Bedrosian, S.R.2
Daniels, E.3
Duquette, D.4
Hampel, H.5
Jasperson, K.6
Joseph, D.A.7
Kaye, C.8
Lubin, I.9
Meyer, L.J.10
Reyes, M.11
Scheuner, M.T.12
Schully, S.D.13
Senter, L.14
Stewart, S.L.15
St Pierre, J.16
Westman, J.17
Wise, P.18
Yang, V.W.19
Khoury, M.J.20
more..
-
11
-
-
0030461680
-
From genes to public health: The applications of genetic technology in disease prevention. Genetics Working Group
-
Khoury MJ: From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group. Am J Public Health 1996; 86:1717-1722.
-
(1996)
Am J Public Health
, vol.86
, pp. 1717-1722
-
-
Khoury, M.J.1
-
12
-
-
77949444879
-
A framework for public health action: The health impact pyramid
-
Frieden TR: A framework for public health action: the health impact pyramid. Am J Public Health 2010; 100: 590-595.
-
(2010)
Am J Public Health
, vol.100
, pp. 590-595
-
-
Frieden, T.R.1
-
13
-
-
84857058760
-
Using core public health functions to promote BRCA best practices among health plans
-
Duquette D, Lew is K, McLosky J, Bach J: Using core public health functions to promote BRCA best practices among health plans. Public Health Genomics 2012; 15:92-97.
-
(2012)
Public Health Genomics
, vol.15
, pp. 92-97
-
-
Duquette, D.1
Lewis, K.2
McLosky, J.3
Bach, J.4
-
14
-
-
84870837661
-
-
accessed February 29, 2012
-
http://intranet.cdc.gov/osels/phspo/bc/bc -registry-profiles/Profile- Behavioral-Risk-Factor-Surveillance-System-BRFSS.pdf (accessed February 29, 2012).
-
-
-
-
15
-
-
78650158157
-
Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians
-
Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ: Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med 2011; 40:61-66.
-
(2011)
Am J Prev Med
, vol.40
, pp. 61-66
-
-
Bellcross, C.A.1
Kolor, K.2
Goddard, K.A.3
Coates, R.J.4
Reyes, M.5
Khoury, M.J.6
-
16
-
-
46049089154
-
-
National Cancer Institute accessed February 29, 2012
-
National Cancer Institute: Breast Cancer. 2012. http://www.cancer.gov/ cancertopics/types/breast (accessed February 29, 2012).
-
(2012)
Breast Cancer
-
-
-
17
-
-
57149130267
-
-
National Cancer Institute accessed February 29, 2012
-
National Cancer Institute: Ovarian Cancer. 2012. http://www.cancer.gov/ cancertopics/types/ovarian (accessed February 29, 2012).
-
(2012)
Ovarian Cancer
-
-
-
18
-
-
78649996861
-
-
National Cancer Institute accessed February 29, 2012
-
National Cancer Institute: BRCA1 and BRCA2: Cancer Risk and Genetic Testing. 2009. http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA #r4 (accessed February 29, 2012).
-
(2009)
BRCA1 and BRCA2: Cancer Risk and Genetic Testing.
-
-
-
19
-
-
33646537461
-
Disparities in genetic testing: Thinking outside the BRCA box
-
Hall MJ, Olopade OI: Disparities in genetic testing: thinking outside the BRCA box. J Clin Oncol 2006; 24:2197-2203.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2197-2203
-
-
Hall, M.J.1
Olopade, O.I.2
-
20
-
-
78650844345
-
The search for unaffected individuals with Lynch syndrome: Do the ends justify the means?
-
Hampel H, de la Chapelle A: The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila) 2011; 4:1-5.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1-5
-
-
Hampel, H.1
De La Chapelle, A.2
-
21
-
-
77149122082
-
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
-
Mvundura M, Grosse SD, Hampel H, Palo-maki GE: The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 2010; 12:93-104.
-
(2010)
Genet Med
, vol.12
, pp. 93-104
-
-
Mvundura, M.1
Grosse, S.D.2
Hampel, H.3
Palo-Maki, G.E.4
-
22
-
-
84857619617
-
Cascade screening for familial hypercholesterolemia (FH)
-
Ned RM, Sijbrands EJ: Cascade screening for familial hypercholesterolemia (FH). PLoS Curr 2011; 3:RRN1238.
-
(2011)
PLoS Curr
, vol.3
-
-
Ned, R.M.1
Sijbrands, E.J.2
-
23
-
-
0025944056
-
Risk of fatal coronary heart disease in familial hypercholesterolemia. Scientific Steering Committee on behalf of the Simon Broome Register Group
-
Risk of fatal coronary heart disease in familial hypercholesterolemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ 1991; 303: 893-896.
-
(1991)
BMJ
, vol.303
, pp. 893-896
-
-
-
24
-
-
12244262220
-
Family history assessment: Strategies for prevention of cardiovascular disease
-
Hunt SC, Gwinn M, Adams T: Family history assessment: strategies for prevention of cardiovascular disease. Am J Prev Med 2003; 24: 136-142.
-
(2003)
Am J Prev Med
, vol.24
, pp. 136-142
-
-
Hunt, S.C.1
Gwinn, M.2
Adams, T.3
-
25
-
-
79953230423
-
Prevention of intellectual disability through screening for congenital hypothyroidism: How much and at what level?
-
Grosse SD, Van Vliet G: Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child 2011; 96: 374-379.
-
(2011)
Arch Dis Child
, vol.96
, pp. 374-379
-
-
Grosse, S.D.1
Van Vliet, G.2
-
26
-
-
1342269036
-
Centers for Disease Control and Prevention: Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003
-
Centers for Disease Control and Prevention: Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003. MMWR Morb Morta l Wkly Rep 2004; 53: 57-59.
-
(2004)
MMWR Morb Morta L Wkly Rep
, vol.53
, pp. 57-59
-
-
-
27
-
-
77954275935
-
How much does IQ raise earnings? Implications for regulatory impact analyses
-
Grosse SD: How much does IQ raise earnings? Implications for regulatory impact analyses. AERE NL 2007; 27:17-21.
-
(2007)
AERE NL
, vol.27
, pp. 17-21
-
-
Grosse, S.D.1
-
28
-
-
57849158453
-
Education cost savings from early detection of hearing loss: New findings
-
Grosse SD: Education cost savings from early detection of hearing loss: new findings. Volta V 2007; 14:38-40.
-
(2007)
Volta v
, vol.14
, pp. 38-40
-
-
Grosse, S.D.1
-
29
-
-
0033997009
-
The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: A decision analysis
-
Tengs TO, Berry DA: The cost effectiveness of testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis. Dis Manage Clin Outcomes 2000; 2:15-24.
-
(2000)
Dis Manage Clin Outcomes
, vol.2
, pp. 15-24
-
-
Tengs, T.O.1
Berry, D.A.2
-
30
-
-
7044224630
-
Genetic counseling program in familial breast cancer: Analysis of its effectiveness, cost and cost-effectiveness ratio
-
Balmaña J, Sanz J, Bonfill X, Casado A, Rué M, Gich I, Díez O, Sabaté JM, Baiget M, Alonso MC: Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Int J Cancer 2004; 112:647-652.
-
(2004)
Int J Cancer
, vol.112
, pp. 647-652
-
-
Balmaña, J.1
Sanz, J.2
Bonfill, X.3
Casado, A.4
Rué, M.5
Gich, I.6
Díez, O.7
Sabaté, J.M.8
Baiget, M.9
Alonso, M.C.10
-
31
-
-
33645646949
-
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
-
Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR: Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med 2006; 144:397-406.
-
(2006)
Ann Intern Med
, vol.144
, pp. 397-406
-
-
Anderson, K.1
Jacobson, J.S.2
Heitjan, D.F.3
Zivin, J.G.4
Hershman, D.5
Neugut, A.I.6
Grann, V.R.7
|